Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Groner

Showing results (151-160 of 198) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytesU Altenschmidt, R Kahl, D Moritz, et al.
The Journal of Biological Chemistry|July 15, 1989
Ha-ras activates the Na+/H+ antiporter by a protein kinase C-independent mechanismK Maly, F Uberall, H Loferer, et al.
The Journal of Biological Chemistry|January 13, 2001
Conversion of threonine 757 to valine enhances Stat5a transactivation potentialP M Gowri, T C Ganguly, J Cao, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1988
v-myc alters the response of a cloned mouse mammary epithelial cell line to lactogenic hormonesR K Ball, A Ziemiecki, C A Schönenberger, et al.
Oncogene|March 1, 1988
The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependentS M Redmond, E Reichmann, R G Müller, et al.
International Journal of Cancer|March 30, 2000
Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivoM Azemar, M Schmidt, F Arlt, et al.
Blood|March 21, 1998
Purging of mammary carcinoma cells during ex vivo culture of CD34+ hematopoietic progenitor cells with recombinant immunotoxinsA Spyridonidis, M Schmidt, W Bernhardt, et al.
European Journal of Biochemistry|March 10, 1998
Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunitsR Moriggl, I Erhardt, W Kammer, et al.
Gynecologic Oncology|February 13, 2001
Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2M Schmidt, A McWatters, R A White, et al.
The Journal of Biological Chemistry|October 10, 1977
Immunoadsorption of specific chicken oviduct polysomes. Isolation of ovalbumin, ovomucoid, and lysozyme messenger RNAB Groner, N E Hynes, A E Sippel, et al.
Pageof 20

Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytesU Altenschmidt, R Kahl, D Moritz, et al.
The Journal of Biological Chemistry|July 15, 1989
Ha-ras activates the Na+/H+ antiporter by a protein kinase C-independent mechanismK Maly, F Uberall, H Loferer, et al.
The Journal of Biological Chemistry|January 13, 2001
Conversion of threonine 757 to valine enhances Stat5a transactivation potentialP M Gowri, T C Ganguly, J Cao, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1988
v-myc alters the response of a cloned mouse mammary epithelial cell line to lactogenic hormonesR K Ball, A Ziemiecki, C A Schönenberger, et al.
Oncogene|March 1, 1988
The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependentS M Redmond, E Reichmann, R G Müller, et al.
International Journal of Cancer|March 30, 2000
Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivoM Azemar, M Schmidt, F Arlt, et al.
Blood|March 21, 1998
Purging of mammary carcinoma cells during ex vivo culture of CD34+ hematopoietic progenitor cells with recombinant immunotoxinsA Spyridonidis, M Schmidt, W Bernhardt, et al.
European Journal of Biochemistry|March 10, 1998
Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunitsR Moriggl, I Erhardt, W Kammer, et al.
Gynecologic Oncology|February 13, 2001
Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2M Schmidt, A McWatters, R A White, et al.
The Journal of Biological Chemistry|October 10, 1977
Immunoadsorption of specific chicken oviduct polysomes. Isolation of ovalbumin, ovomucoid, and lysozyme messenger RNAB Groner, N E Hynes, A E Sippel, et al.
Pageof 20